Evidence Library
Filter by drug, type, year, and open access.
Showing 1–3 of 3 results
- Effects of Long-Term Treatment with TV-46000 on Symptom Improvement Over Time in Stabilized Patients with Schizophrenia — CNS Drugs (2026)• Drug: risperidone-uzedyPMID
- An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans — Pharmaceutics (2025)• Drug: risperidone-uzedyOpen accessDOIPMIDPMCID
- Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human — Pharmaceutics (2024)• Drug: risperidone-uzedyOpen accessDOIPMIDPMCID